Duffy himself commented as this: “My years at Merck, from inception of the Keytruda programs, have been exciting and invaluable. As I look forward now to the next wave of advances in immune therapies for cancer, I am excited about the potential of NW Bio’s DCVax technologies to deliver new breakthroughs for patients. I hope to build on my experience in immuno-oncology and my network of relationships in the field to help NW Bio achieve this potential.” months or so why he went back to Merck.
Guys, there are fudsters here you know who they are. Just do your due diligence. Me and my minions are going All In!